Low-value care practice in headache: a Spanish mixed methods research study.
Care
Cost
Do not Do recommendations
Headache
Mixed methods
Patient safety
Journal
The journal of headache and pain
ISSN: 1129-2377
Titre abrégé: J Headache Pain
Pays: England
ID NLM: 100940562
Informations de publication
Date de publication:
10 Jun 2020
10 Jun 2020
Historique:
received:
07
04
2020
accepted:
04
06
2020
entrez:
12
6
2020
pubmed:
12
6
2020
medline:
8
10
2020
Statut:
epublish
Résumé
Headache is one of the most prevalent diseases. The Global Burden of Disease Study ranks it as the seventh most common disease overall and the second largest neurological cause of disability in the world. The "Do Not Do" recommendations are a strategy for increasing the quality of care and reducing the cost of care for headache. This study aimed to identify specific low-value practices in headache care, determine their frequency, and estimate the cost overrun that they represent, in order to establish "Do not Do" recommendations specifically for headache by consensus and according to scientific evidence. This was a mixed methods research study that combined qualitative consensus-building techniques, involving a multidisciplinary panel of experts to define the "Do Not Do" recommendations in headache care, and a retrospective observational study with review of a randomized set of patient records from the past 6 months in four hospitals, to quantify the frequency of these "Do Not Do" practices. We calculated the sum of direct costs of medical consultations, medicines, and unnecessary diagnostic tests. Seven "Do Not Do" recommendations were established for headache. In total, 3507 medical records were randomly reviewed. Low-value practices had a highly variable occurrence, depending on the hospital and type of headache. Overall, 34.1% of low-value practices were related to treatment, 21% were related to overuse of imaging in consultation, and 19% were related to emergency care. The estimated cost of low-value practices in the four hospitals was 203,520.47 euros per 1000 patients. This study identified low-value headache practices that need to be eradicated and provided data on their frequency and cost overruns.
Sections du résumé
BACKGROUND
BACKGROUND
Headache is one of the most prevalent diseases. The Global Burden of Disease Study ranks it as the seventh most common disease overall and the second largest neurological cause of disability in the world. The "Do Not Do" recommendations are a strategy for increasing the quality of care and reducing the cost of care for headache. This study aimed to identify specific low-value practices in headache care, determine their frequency, and estimate the cost overrun that they represent, in order to establish "Do not Do" recommendations specifically for headache by consensus and according to scientific evidence.
METHODS
METHODS
This was a mixed methods research study that combined qualitative consensus-building techniques, involving a multidisciplinary panel of experts to define the "Do Not Do" recommendations in headache care, and a retrospective observational study with review of a randomized set of patient records from the past 6 months in four hospitals, to quantify the frequency of these "Do Not Do" practices. We calculated the sum of direct costs of medical consultations, medicines, and unnecessary diagnostic tests.
RESULTS
RESULTS
Seven "Do Not Do" recommendations were established for headache. In total, 3507 medical records were randomly reviewed. Low-value practices had a highly variable occurrence, depending on the hospital and type of headache. Overall, 34.1% of low-value practices were related to treatment, 21% were related to overuse of imaging in consultation, and 19% were related to emergency care. The estimated cost of low-value practices in the four hospitals was 203,520.47 euros per 1000 patients.
CONCLUSIONS
CONCLUSIONS
This study identified low-value headache practices that need to be eradicated and provided data on their frequency and cost overruns.
Identifiants
pubmed: 32522142
doi: 10.1186/s10194-020-01147-w
pii: 10.1186/s10194-020-01147-w
pmc: PMC7288523
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Références
Dtsch Arztebl Int. 2018 Jun 1;115(22):365-370
pubmed: 29932046
BMJ Open. 2018 Jun 15;8(6):e021339
pubmed: 29909371
J Am Board Fam Med. 2016 11/12;29(6):710-717
pubmed: 28076254
An Sist Sanit Navar. 2018 Apr 30;41(1):47-55
pubmed: 29465090
Rev Neurol. 2019 Feb 1;68(3):118-122
pubmed: 30687919
Neurologia (Engl Ed). 2020 Apr;35(3):176-184
pubmed: 28870393
Curr Neurol Neurosci Rep. 2015 Jan;15(1):509
pubmed: 25398377
Headache. 2015 Jun;55(6):778-93
pubmed: 25877672
J Gen Intern Med. 2015 Feb;30(2):221-8
pubmed: 25373832
Headache. 2013 Nov-Dec;53(10):1651-9
pubmed: 24266337
J Headache Pain. 2012 Jul;13(5):361-78
pubmed: 22644214
Lancet. 2017 Jul 8;390(10090):156-168
pubmed: 28077234
Neurologia (Engl Ed). 2018 Jul 30;:
pubmed: 30072273
Eur J Neurol. 2012 May;19(5):703-11
pubmed: 22136117
J Headache Pain. 2010 Dec;11(6):451-5
pubmed: 21080023
JAMA Intern Med. 2015 Dec;175(12):1913-20
pubmed: 26457643
Rev Neurol. 2019 Jun 16;68(12):510-516
pubmed: 31173331
Crit Care Med. 2019 Mar;47(3):331-336
pubmed: 30768500
Cureus. 2017 Oct 9;9(10):e1760
pubmed: 29226050
BMJ Qual Saf. 2015 Aug;24(8):523-31
pubmed: 26092165
JAMA. 1998 Sep 16;280(11):1000-5
pubmed: 9749483
BMC Health Serv Res. 2018 Aug 15;18(1):640
pubmed: 30111308
JAMA Intern Med. 2015 Dec;175(12):1921-2
pubmed: 26457364
Headache. 2012 Jan;52(1):3-17
pubmed: 22106869
Neurology. 2019 Jan 15;92(3):134-144
pubmed: 30587518
Neurology. 2013 Sep 10;81(11):1004-11
pubmed: 23430685
Cephalalgia. 2017 Apr;37(5):470-485
pubmed: 27837173
Am J Emerg Med. 2019 Jun;37(6):1037-1043
pubmed: 30177266